Our results show that TLR3 and IRF-3 are expressed in PCa tissues at higher level than in normal human prostate epithelium, supporting the potential application of poly I:C-based therapy, alone or in combination with standard anticancer treatments, for PCa. This evidence concerns the gene IRF3 and posterior cortical atrophy.